Condition: Non-Small Cell Lung Cancer · Non-small Cell Lung Cancer Stage II · Non-Small Cell Lung Cancer Stage IIIA · Sponsor: Memorial Sloan Kettering Cancer Center
The purpose of this study is to find out how many people with HER2-amplified or HER2-mutated non-small cell lung cancer (NSCLC) experience a decrease in tumor viability when they receive trastuzumab deruxtecan before routine surgery to remove tumors.
This description comes directly from the study's public registry record.
James Isbell, MD · 212-639-6247 · isbellj@mskcc.org
Jamie Chaft, MD · 646-608-3761 · chaftj@mskcc.org
Always discuss trial participation with your own doctor first.
| University of Michigan (Data Collection Only) | Ann Arbor, Michigan, United States | Not Yet Recruiting |
| Mayo Clinic (Data Collection Only) | Rochester, Minnesota, United States | Not Yet Recruiting |
| Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) | Basking Ridge, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Monmouth (Limited Protocol Activities) | Middletown, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Bergen (Limited Protocol Activities) | Montvale, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) | Commack, New York, United States | Recruiting |
| Memorial Sloan Kettering Westchester (Limited Protocol Activities) | Harrison, New York, United States | Recruiting |
| Memorial Sloan Kettering Cancer Center (All Protocol Activites) | New York, New York, United States | Recruiting |
| Memorial Sloan Kettering Nassau (Limited Protocol Activites) | Rockville Centre, New York, United States | Recruiting |
| Centre Hospitalier de l'Université de Montreal (Data Collection Only) | Montreal, Quebec, Canada | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07428044